Magenta Therapeutics
Why Robinhood?
You can watch MGTA and buy or sell other stocks, ETFs, and their options commission-free!About MGTA
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.
MGTA Key Statistics
Stock Snapshot
Magenta Therapeutics(MGTA) stock is priced at $11.99, giving the company a market capitalization of 518.24M. It carries a P/E multiple of -18.93.
Magenta Therapeutics(MGTA) stock opened on 2026-03-14 at —. The price climbed to — and dipped to —.
Magenta Therapeutics(MGTA) shares are trading with a volume of 0, against a daily average of 1.98M.
During the past year, Magenta Therapeutics(MGTA) stock moved between $13.37 at its lowest and $88.02 at its peak.
During the past year, Magenta Therapeutics(MGTA) stock moved between $13.37 at its lowest and $88.02 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.